Birchview Capital as of Sept. 30, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 50 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 32.0 | $48M | 794k | 60.29 | |
Accelr8 Technology | 15.6 | $23M | 2.2M | 10.66 | |
Quidel Corporation | 8.6 | $13M | 59k | 219.37 | |
Aspira Womens Health | 6.4 | $9.5M | 3.1M | 3.08 | |
Neurocrine Biosciences (NBIX) | 5.0 | $7.5M | 78k | 96.15 | |
ACADIA Pharmaceuticals (ACAD) | 2.8 | $4.2M | 102k | 41.25 | |
Bluebird Bio (BLUE) | 2.2 | $3.2M | 60k | 53.95 | |
Biogen Idec (BIIB) | 2.1 | $3.1M | 11k | 283.64 | |
Bmy Cvr Rts 03/31/21 Right | 1.8 | $2.7M | 1.2M | 2.25 | |
Karyopharm Therapeutics (KPTI) | 1.6 | $2.5M | 168k | 14.60 | |
Acceleron Pharma | 1.4 | $2.1M | 19k | 112.52 | |
Soleno Therapeutics | 1.4 | $2.1M | 827k | 2.51 | |
Oxford Immunotec Global | 1.3 | $2.0M | 170k | 11.70 | |
Albireo Pharma | 1.3 | $1.9M | 58k | 33.36 | |
Masimo Corporation (MASI) | 1.3 | $1.9M | 8.0k | 236.00 | |
United Therapeutics Corporation (UTHR) | 1.2 | $1.8M | 18k | 101.00 | |
Arena Pharmaceuticals | 1.1 | $1.6M | 22k | 74.77 | |
Chemocentryx | 1.1 | $1.6M | 30k | 54.80 | |
Myokardia | 0.9 | $1.4M | 10k | 136.30 | |
Contrafect | 0.9 | $1.3M | 256k | 5.28 | |
Amarin Corp Spons Adr New (AMRN) | 0.8 | $1.3M | 300k | 4.21 | |
Equitrans Midstream Corp (ETRN) | 0.8 | $1.1M | 133k | 8.46 | |
Harrow Health (HROW) | 0.7 | $1.0M | 180k | 5.59 | |
Corcept Therapeutics Incorporated (CORT) | 0.6 | $870k | 50k | 17.40 | |
Epizyme | 0.6 | $835k | 70k | 11.93 | |
Vanda Pharmaceuticals (VNDA) | 0.5 | $773k | 80k | 9.66 | |
ImmunoGen | 0.5 | $684k | 190k | 3.60 | |
Stoke Therapeutics (STOK) | 0.4 | $670k | 20k | 33.50 | |
Biohaven Pharmaceutical Holding | 0.4 | $650k | 10k | 65.00 | |
Amicus Therapeutics (FOLD) | 0.4 | $537k | 38k | 14.13 | |
Inari Medical Ord (NARI) | 0.3 | $483k | 7.0k | 69.00 | |
Xencor (XNCR) | 0.3 | $477k | 12k | 38.78 | |
Continental Resources | 0.3 | $474k | 39k | 12.28 | |
G1 Therapeutics (GTHX) | 0.3 | $462k | 40k | 11.55 | |
Progyny (PGNY) | 0.3 | $441k | 15k | 29.40 | |
Translate Bio | 0.3 | $408k | 30k | 13.60 | |
Tg Therapeutics (TGTX) | 0.3 | $401k | 15k | 26.73 | |
Kalvista Pharmaceuticals (KALV) | 0.3 | $378k | 30k | 12.60 | |
Arvinas Ord (ARVN) | 0.2 | $354k | 15k | 23.60 | |
Intercept Pharmaceuticals In | 0.2 | $344k | 8.3k | 41.45 | |
Pioneer Natural Resources (PXD) | 0.2 | $327k | 3.8k | 86.05 | |
Voyager Therapeutics (VYGR) | 0.2 | $320k | 30k | 10.67 | |
Inflarx Nv (IFRX) | 0.2 | $298k | 70k | 4.26 | |
Encana Corporation (OVV) | 0.2 | $280k | 34k | 8.15 | |
Odonate Therapeutics Ord | 0.2 | $269k | 20k | 13.45 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $241k | 8.0k | 30.12 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $202k | 8.0k | 25.25 | |
Dicerna Pharmaceuticals | 0.1 | $180k | 10k | 18.00 | |
Yield10 Bioscience | 0.1 | $147k | 19k | 7.76 | |
BioCryst Pharmaceuticals (BCRX) | 0.0 | $69k | 20k | 3.45 |